World’s first and only multi-condition EU MDR Class IIb regulatory approval
Discover what it means for the future of patient-centred care and research.
Read more

Join the conversation

Together we can sharpen our thinking.


In the news

How the UK built a world class tech talent pool

On the path to unicorn status, Huma allows doctors to monitor patients remotely through a mobile app that integrates their data into a dashboard for clinicians to monitor. Since its founding in 2011, it has grown to support a network of more than 27 million patients, and more than 3,000 hospitals and clinics.

Mar 7, 2023
In the news

Bayer taps UK digital health firm for heart risk tool

London, England-based Huma Therapeutics and Bayer have teamed up to develp an online tool where people can check their risk of getting heart disease. The tool does not replace a physician's assessment, the companies caution, but the 15-question assessment may determine if an individual is at a higher, average, or lower risk for developing heart disease.

Mar 3, 2023
In the news

Huma acquires specialised clinical research company Alcedis

Following the acquisition, leading global digital health company Huma will form an advanced clinical trials division offering digital solutions across the entire development pipeline.

Mar 3, 2023
In the news

Huma aquires Alcedis to form clinical trials division

Health tech company Huma Therapeutics is to form an advanced clinical trials division following the acquisition of Alcedis GmbH.

Mar 2, 2023

Discover our patents